Alignment Healthcare (NASDAQ:ALHC) Stock Rating Lowered by Wall Street Zen

Alignment Healthcare (NASDAQ:ALHC) was downgraded by stock analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday.

Several other analysts also recently weighed in on ALHC. TD Cowen boosted their price objective on shares of Alignment Healthcare from $18.50 to $25.00 and gave the stock a “buy” rating in a research report on Friday. Zacks Research downgraded shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. Cowen reiterated a “buy” rating on shares of Alignment Healthcare in a research report on Friday. Barclays raised their price target on Alignment Healthcare from $13.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Friday, October 31st. Finally, JPMorgan Chase & Co. lifted their price target on Alignment Healthcare from $20.00 to $23.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 17th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $21.86.

Alignment Healthcare Stock Performance

NASDAQ:ALHC opened at $22.50 on Friday. Alignment Healthcare has a 1 year low of $11.63 and a 1 year high of $23.19. The stock has a market cap of $4.50 billion, a P/E ratio of -187.50, a P/E/G ratio of 5.92 and a beta of 1.16. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61. The stock has a 50-day simple moving average of $19.21 and a 200-day simple moving average of $16.86.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.03. The business had revenue of $993.70 million for the quarter, compared to analyst estimates of $980.90 million. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The business’s quarterly revenue was up 43.5% on a year-over-year basis. During the same quarter last year, the company earned ($0.14) EPS. As a group, analysts anticipate that Alignment Healthcare will post -0.69 earnings per share for the current fiscal year.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, insider Robert L. Scavo sold 69,541 shares of the company’s stock in a transaction on Monday, December 29th. The shares were sold at an average price of $18.74, for a total transaction of $1,303,198.34. Following the completion of the transaction, the insider owned 503,014 shares in the company, valued at approximately $9,426,482.36. This represents a 12.15% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $22.48, for a total transaction of $674,400.00. Following the completion of the sale, the president owned 1,027,015 shares of the company’s stock, valued at $23,087,297.20. This trade represents a 2.84% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 2,128,532 shares of company stock valued at $40,979,538. Corporate insiders own 7.00% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC boosted its holdings in Alignment Healthcare by 2.6% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 652,648 shares of the company’s stock valued at $13,197,000 after purchasing an additional 16,265 shares in the last quarter. SG Americas Securities LLC boosted its stake in shares of Alignment Healthcare by 148.5% in the fourth quarter. SG Americas Securities LLC now owns 60,390 shares of the company’s stock valued at $1,193,000 after buying an additional 36,084 shares in the last quarter. Assenagon Asset Management S.A. grew its holdings in Alignment Healthcare by 6,708.0% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,774,975 shares of the company’s stock worth $35,056,000 after acquiring an additional 1,748,903 shares during the period. Wealth Enhancement Advisory Services LLC raised its position in Alignment Healthcare by 17.6% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 19,438 shares of the company’s stock worth $414,000 after acquiring an additional 2,909 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in Alignment Healthcare by 83.8% in the fourth quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock valued at $43,000 after acquiring an additional 987 shares during the period. 86.19% of the stock is owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.